The End of Back Pain? Sometimes It’s All In The Head – So Is The Treatment

We all know some people who fake back pain but, as a onetime sufferer myself I know it can be excruciating and very real if sometimes difficult for doctors to diagnose and very difficult to treat. Recent studies show that a back injury can alter brain structure and that an existing drug (not a pain reliever) can help.

Doctors know that many people complaining of back pain are really suffering even though no real cause can be found on x-rays – even worse, the usual battery of pain relievers from NSAIDs to mild narcotics don’t offer much relief.

The BackCare Journal states, “The overarching message that arises from the clinical trials of treatments for chronic low back pain is that current interventions provide only small short term benefits when compared to sham treatment or no treatment.”

http://www.backcare.org.uk/779-6681/The-brain-in-chronic-low-back-pain.html

But there is new hope and a powerful one. The Journal of Neuroscience, vol 26, p 12165 carries a report by A. V. Apkarian, Dept. of Physiology, Northwestern U. School of Medicine which explains that chronic back pain can lead to changes in the brain making the individual more sensitive to the pain. “”The brain is reorganising in these patients. It amplifies the pain signal.”

The important implications include the discovery that low doses cycloserine, an antibiotic used to treat tuberculosis (mycobacterium or MAP infections), dampens activity in that part of the brain in rats.

http://en.wikipedia.org/wiki/Cycloserine

Human clinical trials are beginning soon, but those can take a decade or longer and, since this is an existing drug and the effective dose for reducing back pain is one-fifth the safe dose for treating TB, some patients may wish to let their doctor know about these results and try treatment called off-label, which is perfectly legal and only means using an existing drug to treat something it wasn’t originally developed to treat.

All drugs have side-effects, but one which many people are already taking in higher doses are more likely to be safe than a new drug, especially in treating pain which isn’t effectively managed by analgesics.

Chronic pain which can’t be managed using analgesics is of particular concern because people are prone to taking larger doses of dangerous pain killers in an attempt to get relief.

Although people in great pain can tolerate narcotic doses which are normally fatal – when the narcotics work, I know of no studies showing whether this is also true when the narcotics don’t provide any real relief which is sometimes the case with chronic back pain. Knowing that the pain can cause physical alterations in the brain explains why narcotics, which act by blocking certain chemical signals in the brain, aren’t effective in those cases.

Hot this week

Did David Wineland and Serge Haroche Steal Idea For The Nobel Physics Prize?

Dr. Omerbashich says the Royal Swedish Academy is a Crime Scene and he has the proof that Nobel laureates stole his discovery.

New Approaches to Disaster Relief Challenges

Disaster relief has always been a challenge. NASA, Google,...

3 Legitimate Money Making Methods to Supplement Your Income

In a perfect world, when your landlord raises your...

2016 Predictions by World Renowned Medium and Psychic Lindy Baker

World renowned medium and psychic Lindy Baker is interviewed by The Hollywood Sentinel, discussing psychic power, the spirit world, life after death, areas of concern in 2016, and much more.

Digital Coupon Customers Spending More Than Double At Stores

A new study shows that customers who use digital coupons go shopping more for groceries and other household goods more often and spend more on their shopping trips.

From Luxury Cars to Rush Hour: Staying Safe on Miami Roads

There will always be inherent dangers in getting behind...

Why Is The DNA Company Bringing Behavior Change Into Genetic Education?

Why is The DNA Company adding behavior-change training to DNA University? The answer lies in turning genetic insights into practical action.

How JP Morgan’s Justin Nelson Ties Giving to Estate Plans

Ask a wealthy family how they plan to divide an estate, and the conversation used to stop at percentages: how much to each child, how much to the grandchildren, how much to charity if anything is left over. That conversation has changed. Fo

Bestselling Author Chris Sund Finds 92% of Adults Believe They Are Capable of More

His survey of more than 200 working adults points to a gap that has little to do with talent, and a personal mission to help people close it.

How White-Collar Cases Now Begin With a Document Request, Not a Knock at the Door

A federal grand jury subpoena shows up in the CFO's inbox, addressed to the company, asking for three years of emails, wire records, and board decks. The case is already underway. Nobody kicked in a door. No agent flashed a badge in the lob

The Stokes Interview Is Back: Here’s What Couples Must Decide

Two years ago, plenty of marriage-based green card couples never sat across a desk from a USCIS officer. Interview waivers were common, files moved on paperwork, and the second, split-room interview known as a Stokes was a rare escalation r

Bloom Security Finds a Software Supply Chain Risk Hiding in AI Coding Workflows

AI coding agents are increasingly capable of selecting dependencies,...

Related Articles

Popular Categories